SCHEMBL23557568

SCHEMBL23557568

Oc1ccc(-c2cn(-c3ccccc3OC(F)(F)F)nn2)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MIF P14174 6/20 0.51
▸ HSD17B1 P14061 2/20 0.48
▸ HSD17B2 P37059 2/20 0.48
▸ BCHE P06276 1/20 0.45
▸ ABCG2 Q9UNQ0 3/20 0.42
▸ ABCB1 P08183 1/20 0.40
▸ CD74 P04233 1/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ P2RY14 Q15391 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ LDHA P00338 1/20 0.37
▸ STS P08842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29727007 0.82 OGT (0.59) ABCG2ABCB1P2RY14HDAC7HDAC6
SCHEMBL23557631 0.80 STS (0.61) BCHEABCG2CA12CA1CA2
SCHEMBL23557635 0.80 MIF (0.54) MIFHSD17B1HSD17B2BCHEABCG2
SCHEMBL18031116 0.80 ABCG2 (0.47) MIFHSD17B1HSD17B2BCHEABCG2
SCHEMBL23557702 0.76 CA1 (0.56) MIFHSD17B1HSD17B2P2RY14CA12
SCHEMBL18031102 0.76 CA1 (0.56) MIFHSD17B1HSD17B2P2RY14CA12
SCHEMBL25055359 0.73 MIF (0.74) MIFHSD17B1HSD17B2BCHEABCG2
SCHEMBL18031115 0.72 MAPK14 (0.60) MIFHSD17B1HSD17B2BCHEABCG2
SCHEMBL18031113 0.72 ABCG2 (0.54) MIFBCHEABCG2ABCB1P2RY14
SCHEMBL23557663 0.72 HSD17B1 (0.48) MIFHSD17B1HSD17B2P2RY14CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3790868-B1 SULFAMATE DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, THEIR MEDICAL USE AND THE METHOD OF OBTAINING 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENYL SULFAMATE DERIVATIVES POLITECHNIKA GDANSKA (PL) 2023-01-11 — — EP disclosed
US-20210188785-A1 SULFAMATE DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, THEIR MEDICAL USE AND THE METHOD OF OBTAINING 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENYL SULFAMATE DERIVATIVES POLITECHNIKA GDANSKA (PL) 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188785-A1 SULFAMATE DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, DERIVATIVES OF 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENOL, THEIR MEDICAL USE AND THE METHOD OF OBTAINING 4-(1-PHENYL-1H-[1,2,3]TRIAZOL-4-YL)-PHENYL SULFAMATE DERIVATIVES SULT1E1, SULT2A1, SULT1A1 MIF 1115/4885HSD17B1 136/4885HSD17B2 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback